GSK News and Press, GlaxoSmithKline PLC From 02/26/26

2026-02-26 13:35:52 ET More on leading drugmakers Health Care Q4 Dividend Roundup: Merck Offers Thicker Dividend Cushion Than AbbVie Johnson & Johnson: Strong Run May Be Ending (Rating Downgrade) Merck: Why Investors Should Remain Bullish Despite Patent Risks ...

2026-02-25 23:59:58 ET More on C3.ai C3.ai, Inc. (AI) Q3 2026 Earnings Call Transcript C3.ai: Acquisition Will Likely Only Offer Modest Upside C3.ai's Rule Of -52.1% Performance Contradicts Its AI SaaS Story C3.ai outlines $135M cost reduction plan and 26% he...

2026-02-25 15:50:28 ET More on GSK, Pfizer Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) Pfizer: Recovery Isn't Over, Battered Valuation Still Discounts Its Turnaround ...

2026-02-25 07:19:21 ET More on Pfizer, Merck, etc. Merck: Why Investors Should Remain Bullish Despite Patent Risks Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) ...

2026-02-25 02:14:04 ET More on GSK GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) GSK plc 2025 Q4 - Results - Earnings Call Presentation GSK plc (GSK) Q4 2025 Earnings Call Transcript CDC vaccine panel to meet in March after delay ...

2026-02-24 12:06:38 ET More on Pfizer, Merck, etc. Merck: Why Investors Should Remain Bullish Despite Patent Risks Pfizer: A Risky 6.3% Yield For Income-Oriented Investors Q4 Healthcare Dividends: Johnson & Johnson Kept Outshining Pfizer (Rating Upgrades) ...

2026-02-24 08:51:38 ET More on GSK GSK: Post-Pivot Buoyancy Set To Continue After Strong 2025 (Upgrade) GSK plc 2025 Q4 - Results - Earnings Call Presentation GSK plc (GSK) Q4 2025 Earnings Call Transcript CDC said to delay vaccine panel meeting after lawsuit...

2026-02-23 22:35:52 ET Company Background Electromed ( ELMD ) is a small medical device company based in Minnesota. It was founded in 1992 by Robert D. Hansen and Craig N. Hansen, and it IPO’d in 2010 at $4 a share. Shareholders did pretty poorly in the first 9 years ...

Bora manufactures more than 20 commercial products for GSK at its Mississauga facility, supporting infectious disease, mental health, dermatology, & other critical therapeutic areas Bora Pharmaceuticals Co., Ltd. (“Bora”; TWSE: 6472; OTCQX: BORAY), a global leade...

2026-02-22 08:00:00 ET In my last article, "Merck: Wall Street Surprised By Q3 Strength, Keytruda Sales Surge" , I have been talking mainly about Merck's (MRK) Q3 results and the efficacy of Keytruda+Pfizer’s (PFE) Padcev in the KEYNOTE-905.... Read the full article on ...